Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
The most effective method to Boost Eco-friendliness in Your Volvo XC40 - 2Israel issues notice that Ben-Gurion Airport flights likely restricted until at least April 16
- 3Iranian strikes on Israel injure 11 and set chemical plant ablaze
- 4Argentina joins NASA’s moon return with microsatellite testing GPS beyond Earth
- 5Audits of the Top Science fiction Movies This Year
- Journalist reported killed in the Gaza Strip
- The Best Cell phone Brands for Tech Lovers
- Vote in favor of Your #1 BWM Vehicles
- Germany's far-right AfD tops poll ahead of Merz's conservatives
- UK to hold fresh pork, other affected Spanish products at border amid African swine fever outbreak
- Living Abroad: Social Inundation and Self-improvement
- How to watch ‘The Traitors’ U.K. Season 4 from the U.S.
- Surf Spot Mechanics: Bells Beach
- Paul Feig loves a plot twist. Why not reboot 'Die Hard' starring a woman?
